Compass Therapeutics, Inc.
NASDAQ:CMPX
2.58 (USD) • At close July 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 43.483 | 24.228 | 34.946 | 144.514 | 47.076 | 25.303 | 57.511 |
| Short Term Investments
| 83.239 | 128.233 | 151.663 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 126.722 | 152.461 | 186.609 | 144.514 | 47.076 | 25.303 | 57.511 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.029 | 1.42 | 8.182 | 2.591 | 3.126 | 0.935 | 1.37 |
| Total Current Assets
| 132.751 | 153.881 | 194.791 | 147.105 | 50.202 | 26.238 | 58.881 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 7.084 | 2.674 | 4.534 | 6.332 | 1.126 | 3.751 | 5.367 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0.263 | 0.263 | 0.262 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.568 | 0.32 | 0.32 | 0.32 | 0.32 | 0.129 | 0.115 |
| Total Non-Current Assets
| 7.652 | 2.994 | 4.854 | 6.652 | 1.709 | 4.143 | 5.744 |
| Total Assets
| 140.403 | 156.875 | 199.645 | 153.757 | 51.911 | 30.381 | 64.625 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 2.249 | 4.09 | 3.382 | 0.867 | 1.061 | 0.629 | 1.73 |
| Short Term Debt
| 0.338 | 1.197 | 1.097 | 0.989 | 7.467 | 5.576 | 3.688 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0.555 | 0.519 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 3.122 | 0.519 |
| Other Current Liabilities
| 6.287 | -1.576 | 8.308 | 7.908 | 0.51 | -0.69 | 0.279 |
| Total Current Liabilities
| 8.874 | 7.801 | 16.169 | 10.631 | 10.099 | 9.821 | 8.465 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 6.296 | 0.536 | 1.838 | 3.048 | 1.867 | 9.293 | 11.064 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.001 | 0 | 0 | 0 | 0 | 129.87 | 129.87 |
| Total Non-Current Liabilities
| 6.297 | 0.536 | 1.838 | 3.048 | 1.867 | 139.163 | 140.934 |
| Total Liabilities
| 15.171 | 8.337 | 18.007 | 13.679 | 11.966 | 148.984 | 149.399 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0.13 | 129.87 |
| Common Stock
| 0.013 | 0.013 | 0.013 | 0.01 | 0.005 | 3.305 | 2.39 |
| Retained Earnings
| -364.683 | -315.308 | -272.814 | -233.589 | -151.408 | -121.908 | -87.164 |
| Accumulated Other Comprehensive Income/Loss
| 0.21 | 0.037 | -0.302 | 0 | -0 | -3.435 | -4.096 |
| Other Total Stockholders Equity
| 489.692 | 463.796 | 454.741 | 373.657 | 191.348 | 3.305 | -125.774 |
| Total Shareholders Equity
| 125.232 | 148.538 | 181.638 | 140.078 | 39.945 | -118.603 | -84.774 |
| Total Equity
| 125.232 | 148.538 | 181.638 | 140.078 | 39.945 | -118.603 | -84.774 |
| Total Liabilities & Shareholders Equity
| 140.403 | 156.875 | 199.645 | 153.757 | 51.911 | 30.381 | 64.625 |